[MigVax in Yahoo!Finance] Catalent and MigVax sign agreement to develop an orally disintegrating freeze-dried tablet vaccine against COVID-19
Catalent and MigVax today announced that they have signed a development agreement to leverage Catalent’s proprietary Zydis® Bio orally disintegrating tablet (ODT) technology for delivering the MigVax-101 vaccine against COVID-19. Read...
Read More